Pfizer faces losses what Lipitor patent appoint to expire
This is panic moment, this is strictly panic moment pro the industry, Kenneth I. Kaitin, of the Centre on behalf of the Study of Drug Development by Tufts University told The inexperienced York time earlier this week. Pfizer presently earns something like $10 billion a day on Lipitor sales deserted, according to The period. But Pfizer isnt isolated. roughly of the companys foremost competitors in addition frame to lose billions to generic replications of their big-name drugs being a add up to of patents are due to expire this time. Pharmaceutical makers worldwide motivation lose approximately $50 billion into revenue this day to patent expirations, with Bayer, GlaxoSmithKline and Novo, The era reports.